Ulcer treatment trial for active eye infection
Part of Eyes & vision, Infections clinical trials.
This trial tests a new treatment for people who still have eye inflammation after 1 month of standard treatment for a parasitic eye infection (acanthamoeba keratitis). It aims to find a better way to control the infection and reduce inflammation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of acanthamoeba keratitis (a parasitic eye infection) through tests like culture or PCR.
- You must have active eye inflammation (redness, swelling) after 1 month of anti-amoebic treatment.
- You cannot have certain other eye infections (like herpes or fungus) or a history of certain eye problems.
- You cannot have a hole in your cornea or be at risk for one.
- You cannot have had a cornea transplant for this infection.
- You cannot be using steroid medications for other conditions or have an allergy to steroids.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if adding cyclosporine A to the standard natamycin eye drops can better treat fungal eye infections. It may help people with moderate vision loss from a fungal corneal infection.
This study tests a new light-based treatment for a rare fungal infection of the eye (Fusarium keratitis) that can cause vision loss. It aims to see if this therapy can fight the infection and help preserve or improve your vision.
This trial tests whether resveratrol, a natural substance, can help treat Acanthamoeba keratitis (a rare but serious eye infection). It also looks at a nanoparticle form that may work better. This could offer a new option for people with this condition.
This trial tests a new eye drop (acoltrepon) to see if it helps people with stage 1 neurotrophic keratopathy (a condition where the cornea's nerves are damaged, causing dry eyes and vision problems) and low tear production. It aims to improve signs like corneal staining and symptoms of discomfort.
This trial tests a new eye drop called IVIEW-1201 to see if it works as well as the current standard treatment for fungal keratitis, a serious infection of the cornea. If you have a fungal eye infection confirmed by a lab test and have not used antifungal medications in the last two days, you may be able to join.
This trial tests whether injecting Humira (adalimumab) under the membrane of the eye can improve outcomes for people receiving a special type of artificial cornea called a Boston keratoprosthesis. It is for patients with severe corneal scarring and poor vision.
Hear when a new Acanthamoeba Keratitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.